Linezolid Accord (Linezolid)

Linezolid is an oxazolidinone antibiotic used to manage serious bacterial infections affecting the skin, lungs and resistant organisms.

• Skin and soft tissue infections: effective against susceptible Gram‑positive pathogens, reducing infection severity.
• Community‑acquired pneumonia: provides coverage for typical and atypical organisms, improving respiratory outcomes.
• Hospital‑acquired pneumonia: active against resistant strains, aiding recovery in nosocomial settings.
• Methicillin‑resistant Staphylococcus aureus (MRSA) infections: offers a treatment option when other agents are ineffective.

• Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex. This action blocks the translation process, halting bacterial growth and leading to a bacteriostatic effect against susceptible Gram‑positive organisms.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools that may be self‑limiting.
• Headache: transient cranial discomfort.
• Metallic taste: altered taste perception during therapy.
• Vomiting: occasional emesis.
• Rash: mild skin erythema or pruritus.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count requiring monitoring.
• Peripheral neuropathy: nerve damage presenting as tingling or numbness.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: rare metabolic disturbance.
• Optic neuropathy: visual disturbances that may be irreversible.
• Severe hepatic injury: elevated liver enzymes or liver failure.

Before initiating therapy, clinicians should assess patient‑specific factors and monitor for potential complications.

• Blood count monitoring: check complete blood count regularly to detect thrombocytopenia or anemia.
• Renal function assessment: evaluate kidney function, especially in patients with pre‑existing impairment.
• Hepatic impairment caution: use with care in patients with liver disease, monitoring liver enzymes.
• Serotonergic drug review: avoid concomitant use with MAO inhibitors or SSRIs to prevent serotonin syndrome.
• Hypersensitivity awareness: discontinue if signs of allergic reaction appear.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Linezolid can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of severe hypertension and serotonin syndrome.
• Serotonergic agents (SSRIs, SNRIs, tricyclic antidepressants): may precipitate serotonin syndrome.

Moderate Interactions (Monitor Closely)

• Rifampin: induces metabolism, reducing linezolid plasma levels.
• Anticoagulants (warfarin): may enhance anticoagulant effect, requiring INR monitoring.
• Anticonvulsants (phenytoin, carbamazepine): may lower linezolid concentrations.
• Oral contraceptives: potential reduction in efficacy, advise alternative contraception.